You are here:

FAQ on Genome Editing and CRISPR/Cas9

BfR FAQ, 06 March 2018

Genome editing is a generic term for new methods enabling targeted modifications to the genetic material (genome) of a cell. The CRISPR/Cas9 method in particular holds great promise for new application methods. The German Federal Institute for Risk Assessment (BfR) observes these scientific developments in the interest of consumer health protection. Here the BfR answers the most important questions on the topic of genome editing and notably the CRISPR/Cas9 method.

In November 2016, the Federal Government issued a statement entitled "Classification and management of new genetic engineering techniques".

http://dip21.bundestag.de/dip21/btd/18/103/1810301.pdf

A group of scientific experts from the European Commission published an estimation of new techniques in agricultural biotechnology in April 2017.

http://ec.europa.eu/research/sam/pdf/topics/explanatory_note_new_techniques_agricultural_biotechnology.pdf

Up

FAQs

expand all

FAQ

 (1)
Date Title Size
06.03.2018
BfR FAQ
FAQ on Genome Editing and CRISPR/Cas9 47.2 KB
PDF-File

Up

Keywords

 (1)

nach oben